These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2780414)

  • 1. Analgesic activity of morphiceptin, beta-casomorphin-4, and deltakephalin in normotensive Wistar-Glaxo and spontaneously hypertensive rats.
    Widy-Tyszkiewicz E; Członkowski A
    Peptides; 1989; 10(3):539-44. PubMed ID: 2780414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normotensive Wistar rats differ from spontaneously hypertensive and renal hypertensive rats in their cardiovascular responses to opioid agonists.
    Widy-Tyszkiewicz E; Członkowski A
    Clin Exp Pharmacol Physiol; 1991 Dec; 18(12):797-806. PubMed ID: 1797445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular responses to morphiceptin in spontaneously hypertensive and normotensive rats.
    Widy-Tyszkiewicz E; Członkowski A; Szreniawski Z
    Pol J Pharmacol Pharm; 1986; 38(1):51-6. PubMed ID: 3763486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynorphin: potent analgesic effect in spinal cord of the rat.
    Han JS; Xie CW
    Sci Sin B; 1984 Feb; 27(2):169-77. PubMed ID: 6147015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kappa opioid receptor activity in spontaneously hypertensive rats.
    Bhargava HN; Gulati A
    J Pharmacol Exp Ther; 1988 May; 245(2):460-5. PubMed ID: 2835473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diprotin A, an inhibitor of dipeptidyl aminopeptidase IV(EC 3.4.14.5) produces naloxone-reversible analgesia in rats.
    Rónai AZ; Timár J; Makó E; Erdö F; Gyarmati Z; Tóth G; Orosz G; Fürst S; Székely JI
    Life Sci; 1999; 64(2):145-52. PubMed ID: 10069492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analgesic properties of chimeric peptide based on morphiceptin and PFRTic-amide.
    Li M; Zhou L; Ma G; Dong S
    Regul Pept; 2012 Nov; 179(1-3):23-8. PubMed ID: 22960407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential actions of intrathecal naloxone on blocking the tail-flick inhibition induced by intraventricular beta-endorphin and morphine in rats.
    Tseng LF; Fujimoto JM
    J Pharmacol Exp Ther; 1985 Jan; 232(1):74-9. PubMed ID: 3155550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cerebral ventricles perfusion with morphiceptin and Met-enkephalin on trigemino-hypoglossal reflex in rats.
    Zubrzycka M; Fichna J; Janecka A
    J Physiol Pharmacol; 2002 Dec; 53(4 Pt 2):741-50. PubMed ID: 12510860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An antisense oligodeoxynucleotide to mu-opioid receptors inhibits mu-opioid receptor agonist-induced analgesia in rats.
    Chen XH; Adams JU; Geller EB; DeRiel JK; Adler MW; Liu-Chen LY
    Eur J Pharmacol; 1995 Feb; 275(1):105-8. PubMed ID: 7774656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sites of analgesic action of dynorphin.
    Kaneko T; Nakazawa T; Ikeda M; Yamatsu K; Iwama T; Wada T; Satoh M; Takagi H
    Life Sci; 1983; 33 Suppl 1():661-4. PubMed ID: 6141507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endorphinergic mechanism in the central cardiovascular and analgesic effects of clonidine.
    Kunos G; Mosqueda-Garcia R; Mastrianni JA; Abbott FV
    Can J Physiol Pharmacol; 1987 Aug; 65(8):1624-32. PubMed ID: 3690393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of central mu-opioid receptors is involved in clonidine analgesia in rats.
    Mastrianni JA; Abbott FV; Kunos G
    Brain Res; 1989 Feb; 479(2):283-9. PubMed ID: 2538210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of mu and delta opioid peptides of various selectivity gives further evidence of specific involvement of mu opioid receptors in supraspinal analgesia (tail-flick test).
    Dauge V; Petit F; Rossignol P; Roques BP
    Eur J Pharmacol; 1987 Sep; 141(2):171-8. PubMed ID: 2824213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Augmented analgesic effects of enkephalinase inhibitors combined with transcranial electrostimulation.
    Malin DH; Lake JR; Hamilton RF; Skolnick MH
    Life Sci; 1989; 44(19):1371-6. PubMed ID: 2716474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for a supraspinal mechanism in the opioid-mediated antinociceptive effect of ketamine.
    Baumeister A; Advokat C
    Brain Res; 1991 Dec; 566(1-2):351-3. PubMed ID: 1814555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of tail-flick and shaking responses by intrathecal and intraventricular D-Ala2-D-Leu5-enkephalin and beta-endorphin in anesthetized rats.
    Tseng LF; Cheng SS; Fujimoto JM
    J Pharmacol Exp Ther; 1983 Jan; 224(1):51-4. PubMed ID: 6294283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isobolographic superadditivity between delta and mu opioid agonists in the rat depends on the ratio of compounds, the mu agonist and the analgesic assay used.
    Adams JU; Tallarida RJ; Geller EB; Adler MW
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1261-7. PubMed ID: 8396630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of beta-casomorphin-5 on passive avoidance response in mice.
    Sakaguchi M; Koseki M; Wakamatsu M; Matsumura E
    Biosci Biotechnol Biochem; 2003 Nov; 67(11):2501-4. PubMed ID: 14646221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of systemic administration of beta-casomorphin-5 on learning and memory in mice.
    Sakaguchi M; Koseki M; Wakamatsu M; Matsumura E
    Eur J Pharmacol; 2006 Jan; 530(1-2):81-7. PubMed ID: 16360145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.